We determined that IKAROS regulates CD19 expression in B-ALL, large B cell lymphoma (LBCL), and chronic lymphoblastic lymphoma (CLL) models. This evidence concerns the gene IKZF1 and precursor B-cell acute lymphoblastic leukemia.